# Prescryptive Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/prescryptive-health

- Industry: Internet
- Headquarters: Redmond, US
- Website: www.prescryptive.com
- Total disclosed funding: $26M
- Latest round: Series A (Aug 25, 2020)
- Investors on record: 4

## About

Prescryptive Health, Inc. is a healthcare technology company that enhances prescription management through innovative digital solutions, focusing on patient empowerment and operational efficiency for pharmacies and healthcare providers.Founded in 2017 in Redmond, US, Prescryptive Health, Inc. specializes in healthcare technology solutions. The company has successfully raised USD 26 mn in Series A funding on August 25, 2020, led by Morningside Venture Capital, with contributions from SeaChange Fund and Pallasite Ventures.Prescryptive Health offers a comprehensive healthcare technology platform designed to empower patients through better management of their prescriptions and healthcare decisions. Central to its offerings is the myPrescryptive® platform, which provides real-time alerts and insights, enabling patients to track and manage their prescriptions securely, all without the need for a separate app. The platform employs an AI-optimized pricing tool that enhances pharmacy profitability and provides transparent pricing to patients, eliminating surprises at the pharmacy counter. Targeted primarily at consumers, employers, independent pharmacies, and healthcare systems, Prescryptive serves a diverse customer base across various geographical markets, including urban and suburban areas in the United States. This integrated approach addresses key use cases such as improving medication adherence, reducing out-of-pocket costs, and streamlining the prescription process for both patients and pharmacy partners.Prescryptive Health generates revenue through a multifaceted transaction structure that includes both B2B and direct-to-consumer models. The company collaborates with independent pharmacies to enhance their operational workflow, which may involve subscription-based access to the myPrescryptive platform. Clients, such as employers and healthcare providers, may engage in partnerships to implement voluntary prescription plans aimed at reducing costs for employees and their dependents. The transparency of their pricing model, particularly with the AI-optimized pricing tool, contributes to the financial support for pharmacies while offering competitive rates to consumers. Revenue is driven by the scale of prescriptions processed on the platform and the uptake of services from various healthcare stakeholders, ensuring a steady flow of transactions associated with their flagship offerings.The recent Series A funding of USD 26 mn will enable Prescryptive Health to expand its product offerings and enhance its technological capabilities. Future plans include the launch of new features within the myPrescryptive platform aimed at improving user engagement and prescription management. The company is also targeting expansion into additional markets across the United States by the end of 2023, focusing on increasing its reach among independent pharmacies and healthcare systems. This growth strategy is designed to leverage the recent investment to facilitate operational enhancements and broaden the platform's capabilities.

## Funding rounds

- Series A, Aug 25, 2020, $26M — 5Y Capital, Pallasite Ventures, SeaChange
- Seed, Apr 1, 2019 — Pool Global Partners

## Investors

- Pool Global Partners (https://capitalatlas.ai/funds/pool-global-partners) — Seed
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series A
- Pallasite Ventures (https://capitalatlas.ai/funds/pallasite-ventures) — Series A
- SeaChange (https://capitalatlas.ai/funds/seachange) — Series A